New York, NY (PRWEB) June 22, 2014
Nearly 60,000 vaginal mesh lawsuits (http://www.injurybeacon.com/transvaginal-mesh/lawsuit/) have now been filed in seven federal multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports.
According to court documents, a Case List updated on June 16th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) reflects a significant increase in the number of claims now pending in the federal transvaginal mesh proceedings, many of which involve products marketed by the Johnson & Johnson subsidiary, Ethicon (MDL No. 2327) , as well as C.R. Bard Inc., (MDL No. 2187), American Medical Systems (No. 2325) and Boston Scientific (MDL No. 2326).
In the federal litigation involving Ethicon mesh, for example, a total of 18,176 claims have now been filed, while more than 17,800 are pending in the American Medical Systems proceeding. Court filings indicate that all transvaginal mesh cases in the Southern District of West Virginia were filed by women who claim to have experienced mesh erosion, pain during sexual intercourse, chronic pain and/or other complications caused by implants used to repair pelvic organ prolapse (POP) or stress urinary incontinence (SUI).
“As our Firm is representing numerous women in the federal transvaginal mesh litigations now underway in West Virginia, we are pleased to see these litigations moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who may have been injured as a result of transvaginal mesh.
Vaginal Mesh Lawsuits
In four of the federal transvaginal mesh litigations moving forward in the Southern District of West Virginia, Jeffrey S. Grand, a partner at Bernstein Liebhard LLP is actively serving on the Plaintiffs’ Steering Committee. These proceedings include: In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327, In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187.
In addition to the transvaginal mesh claims filed in West Virginia federal court, thousands of other lawsuits concerning these products continue to move forward in state courts across the U.S.
Two separate consolidated litigations have been created in New Jersey’s Atlantic County
Superior Court for lawsuits against C.R. Bard Inc., and Johnson & Johnson’s Ethicon unit, court records indicate. A Case List updated on June 16th indicates that over 5,060 lawsuits have been filed in the Ethicon proceeding, and 1,379 are now included in the one involving C.R. Bard implants. Mr. Grand is serving as Co-Liaison Counsel in both of these transvaginal mesh proceedings. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Although there has not yet been an industry-wide recall of these products, women who may have been harmed by pelvic mesh devices used to treat pelvic organ prolapse or stress urinary incontinence may be entitled to file a vaginal mesh lawsuit seeking compensation for their injury related damages. Learn more about vaginal mesh lawsuits by visiting Bernstein Liebhard LLP’s website. Free legal reviews can also be obtained by calling 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP